{"url_path":"/sec/adil/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1513525/0001213900-26-053907-index.html","accession_number":"0001213900-26-053907","cik":"0001513525","ticker":"ADIL","issuer_name":"ADIAL PHARMACEUTICALS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1513525/0001213900-26-053907-index.html","primary_entity_key":"0001513525","primary_entity_name":"ADIAL PHARMACEUTICALS, INC."},"word_count":66,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities\nand Use of Proceeds.\n\n \n\n*(a) Unregistered Sales of Equity Securities*\n\n \n\nWe did not sell any equity securities during the\nthree months ended March 31, 2026 in transactions that were not registered under the Securities Act other than as disclosed in our filings\nwith the SEC.\n\n \n\n*(b) Use of Proceeds*\n\n \n\nNot applicable.\n\n \n\n*(c) Issuer Purchases of Equity Securities*\n\n \n\nNot applicable."}